10x Genomics, Inc. (TXG) earnings
TXG earnings moved a median of +2.14% by the close. Quarterly and annual TXG reports and results, each read against the price at its own news timestamp. Back to the TXG overview →
30 measured TXG earnings events.
Where these TXG earnings landedvs 30 measured TXG earnings reactions
| Middle 50% of TXG earnings reactions | -2.47% to +5.39% |
|---|---|
| Median reaction (to close) | +2.14% |
| Measured reactions | 30 |
Point-in-time · zero look-ahead
Half of the 30 TXG earnings events with a measured close landed between -2.47% and +5.39%; 67% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| 10x Genomics to Report Third Quarter 2026 Financial Results on November 5, 2026 | Press release | +2.01% | +5.03% | |
| Form 10-Q 10x Genomics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +2.52% | +16.22% | |
| 10x Genomics Reports Second Quarter 2026 Financial Results | Press release | +2.52% | +16.22% | |
| 10x Genomics to Report Second Quarter 2026 Financial Results on August 6, 2026 | Press release | -0.19% | -1.00% | |
| Form 10-Q 10x Genomics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.33% | +2.52% | |
| 10x Genomics Reports First Quarter 2026 Financial Results | Press release | -1.33% | +2.52% | |
| 10x Genomics to Report First Quarter 2026 Financial Results on May 7, 2026 | Press release | -0.57% | -0.47% | |
| Form 10-K 10x Genomics, Inc. For: Dec 31 | SEC filing · Form 10-K | +2.82% | -5.82% | |
| Form 10-Q 10x Genomics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.66% | +5.39% | |
| 10x Genomics Reports Third Quarter 2025 Financial Results | Press release | -1.66% | +5.39% | |
| 10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025 | Press release | -0.42% | -2.96% | |
| Form 10-Q 10x Genomics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -12.90% | -15.18% | |
| 10x Genomics Reports Second Quarter 2025 Financial Results | Press release | -12.90% | -15.18% | |
| 10x Genomics to Report Second Quarter 2025 Financial Results on August 7, 2025 | Press release | +0.41% | +3.90% | |
| Form 10-Q 10x Genomics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.22% | -10.51% | |
| 10x Genomics Reports First Quarter 2025 Financial Results | Press release | -1.22% | -10.51% | |
| 10x Genomics to Report First Quarter 2025 Financial Results on May 8, 2025 | Press release | +2.45% | +0.12% | |
| Form 10-K 10x Genomics, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.67% | +7.57% | |
| 10x Genomics Reports Third Quarter 2024 Financial Results | Press release | +5.81% | +6.39% | |
| Form 10-Q 10x Genomics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +5.81% | +6.39% | |
| 10x Genomics Announces Preliminary Select Third Quarter 2024 Results | Press release | -3.91% | +4.82% | |
| 10x Genomics Reports Second Quarter 2024 Financial Results | Press release | -1.49% | -4.71% | |
| Form 10-Q 10x Genomics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -1.49% | -4.71% | |
| 10x Genomics to Report Second Quarter 2024 Financial Results on August 8, 2024 | Press release | +0.86% | +0.23% | |
| 10x Genomics Reports First Quarter 2024 Financial Results | Press release | -0.60% | +1.58% | |
| Form 10-Q 10x Genomics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.60% | +1.58% | |
| 10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024 | Press release | -1.23% | +1.76% | |
| Form 10-K 10x Genomics, Inc. For: Dec 31 | SEC filing · Form 10-K | +5.67% | +2.84% | |
| Form 10-Q 10x Genomics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +2.46% | +10.33% | |
| 10x Genomics Reports Third Quarter 2023 Financial Results | Press release | +2.46% | +10.33% |
Keep exploring
More TXG: analyst actions → · SEC filings → · TXG overview →